- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Bioniche Life Sciences Inc
+ Add to WatchlistBJF:GR
0.204 EUR 0.007 3.32%As of 09:36:46 ET on 05/23/2013.
Snapshot for Bioniche Life Sciences Inc (BJF)
| Open: | 0.253 | Day's Range: | 0.204 - 0.253 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.211 | 52wk Range: | 0.127 - 0.532 | 1-Yr Rtn: | -35.03% |
Key Statistics for BJF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (06/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/12/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BJF
Company Profile & Key Executives for BJF
Bioniche Life Sciences Inc. is a biopharmaceutical company. The Company researches, develops, and commercializes technologies for the human and veterinary markets. Bioniche operates through its Vetrepharm Animal Health, Bioniche Therapeutics, and Bioniche Pharma divisions.
| Graeme K M McRaePresident/CEO | Brian R FordVP/CFO/Investor Relations |
| Michael RubinVP:Business Development | Monique ChampagneVP:Clinical Research |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BJF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page